There’s a lot to be said for going with the category killer in an investment. A merger is creating exactly that in the prescription service space. More
MHS
Recent Articles
Sweet Day for Shipping — Monday’s IP Market Recap
A tiny rise in the Baltic Dry Index spurs big stock gains for several shipping companies. More
Walgreen Not Sweating Loss of Express Scripts Customers to CVS — Should It Be?
CVS says it could gobble up to 23M prescriptions that Walgreens has sold through Express Scripts if a deal isn't announced. So far, WAG is sticking to its guns. More
Campaign to Kill Medco-Express Scripts Deal Likely Futile
It's not very likely that major pharmaceuticals will be able to prevent Express Scripts from acquiring Medco. But they do have good reason to try. More
Sides Form on Medco-Express Scripts Deal
With the Federal Trade Commission likely to give the deal a close eye, analysts and investors sound off varying degrees of optimism and pessimism about this venture. More
SFN, Medco Continue to Top Trading
Midday Trading Led By SFN Group (NYSE: SFN), Medco Health Solutions (NYSE: MHS), Express Scripts (NASDAQ: ESRX). More
Should You Buy Medco Health?
Buyout offer from Express Scripts makes this an interesting stock, but absent a bidding war, you might be better off avoiding MHS More
